UnknownEarly Phase 1

Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection

20 participantsStarted 2015-03

Plain-language summary

A pilot study of the effects of 3 retro-calcaneal hyalin G-F 20 injection on the clinical and radiological changes in 20 adult patients with changes in insertional achilles tendinopathy.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Previous surgical treatment.
✕. Previous HA(Hyaluronic Acid), PRP (Platelet Rich Plasma) or steroids injection in the last 6 months.
✕. Previous two or more steroids injection.
✕. Plantaris muscle injury.
✕. Posterior ankle impingement.
✕. Achilles tendon rapture.
✕. Previous calcaneal fracture

What they're measuring

Change in the VISA-A questionnaire score

Timeframe: Change in the VISA-A questionnaire score during 6 months follow-up

Trial details

NCT IDNCT02368561

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-01

Contact for this trial

Ezequiel Palmanovich, Dr

972-5250868 ezepalm@gmail.com

View on ClinicalTrials.gov More Insertional Achilles Tendinitis trials